Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
7(44%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
25%
Ph phase_1
2
13%
Ph phase_3
1
6%
Ph phase_2
2
13%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

7

trials recruiting

Total Trials

16

all time

Status Distribution
Active(10)
Completed(3)
Terminated(1)
Other(2)

Detailed Status

Active, not recruiting4
Recruiting3
Completed3
unknown2
Enrolling by invitation2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
7
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (22.2%)
Phase 22 (22.2%)
Phase 31 (11.1%)
N/A4 (44.4%)

Trials by Status

not_yet_recruiting16%
active_not_recruiting425%
unknown213%
withdrawn16%
recruiting319%
enrolling_by_invitation213%
completed319%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT04530565Phase 3

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Active Not Recruiting
NCT05901545Phase 1

Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

Recruiting
NCT04659616Phase 1

Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia

Recruiting
NCT06101940

A Multicenter Phenotype-Genotype Analysis of DM1 Patients in China

Enrolling By Invitation
NCT03399773Phase 2

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Active Not Recruiting
NCT06304233

The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease

Active Not Recruiting
NCT06936150

Effect of Tourniquet Use on ICEB and ICEBc in Upper Extremity Surgeries

Completed
NCT06812767

Risk Factors at Chronic Non-communicable Diseases in People of Working Age

Enrolling By Invitation
NCT05000957Not Applicable

Pelvic Organs Prolapse Treatment Using Neodymium Laser

Active Not Recruiting
NCT05703126Not Applicable

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Recruiting
NCT06637748Not Applicable

Echo and Electrocardiographic Findings in Children With Bronchial Asthma At Sohag University Hospital

Not Yet Recruiting
NCT06608784

Comparison Study of Electrocardiogram Indexes in Patients With Epilepsy, Patients With First Seizure and Normal Population

Completed
NCT06398587Phase 2

Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma

Withdrawn
NCT02168049Not Applicable

Heart and Lung Function Monitoring System

Completed
NCT05448716

Left Atrial Strain and Supraventricular Arrhythmia Burden in Cardiac Light Chain Amyloidosis Following Chemotherapy

Unknown
NCT02380365

QT-Prolongation in Lung Transplantation

Unknown

All 16 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
16